Skip to main content

ROYAL LONDON ASSET MANAGEMENT LTD

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 863748 UNITED KINGDOM, X0

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,423,699
-$604,277 QoQ
Shares Held
3,887
-0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#492
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL LONDON ASSET MANAGEMENT LTD holds $597,315,774 across 9 Biotechnology names. REGN ranks #6 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 REGN
Regeneron Pharmaceuticals, Inc.
This page
3,887 $2,423,699

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,423,699 3,887
2026-03-31 $3,027,976 3,919
2025-12-31 $3,257,291 4,220
2025-09-30 $2,534,150 4,507
2025-06-30 $24,449,775 46,571
2025-03-31 $31,478,103 49,632
2024-12-31 $31,402,355 44,084
2024-09-30 $45,912,907 43,675
2024-06-30 $44,692,948 42,523
2024-03-31 $39,519,839 41,060
2023-12-31 $36,579,900 41,649
2023-09-30 $33,396,539 40,581
2023-06-30 $27,972,043 38,929
2023-03-31 $30,153,645 36,698
2022-12-31 $26,584,742 36,847
2022-09-30 $24,126,294 35,023
2022-06-30 $21,474,570 36,328
2022-03-31 $25,151,501 36,012
2021-12-31 $21,586,616 34,182
2021-09-30 $21,050,581 34,784
2021-06-30 $19,142,282 34,272
2021-03-31 $17,094,548 36,130
2020-12-31 $16,976,485 35,140
2020-09-30 $20,941,929 37,411
2020-06-30 $23,351,326 37,443
2020-03-31 $15,489,047 31,721